Q3 2023
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
ALPN | New | Alpine Immune Sciences, Inc. | $76,809,898 | – | 6,708,288 | – | 25.63% | – |
Buy | Aura Biosciences, Inc. | $18,243,928 | +403.6% | 1,163,123 | +296.5% | 6.09% | +436.0% | |
New | ROIVANT SCIENCES LTD | $17,049,296 | – | 1,459,700 | – | 5.69% | – | |
Sell | ACELYRIN INC(NSM) | $15,746,384 | -51.5% | 1,548,317 | -0.4% | 5.26% | -48.4% | |
LNTH | New | LANTHEUS HOLDINGS INC(NMS) | $9,879,778 | – | 142,196 | – | 3.30% | – |
IMGN | New | IMMUNOGEN INC | $6,600,016 | – | 415,880 | – | 2.20% | – |
SGEN | New | SEAGEN INC | $4,882,420 | – | 23,014 | – | 1.63% | – |
BYSI | New | BeyondSpring Inc. | $3,966,514 | – | 4,958,143 | – | 1.32% | – |
ATRC | New | AtriCure Inc. | $2,026,144 | – | 46,259 | – | 0.68% | – |
New | Pyxis Oncology, Inc (formerly Apexigen) | $650,352 | – | 326,810 | – | 0.22% | – | |
New | GeneDx Holdings Corp. | $377,118 | – | 103,604 | – | 0.13% | – | |
ACET | Sell | Adicet Bio, Inc. | $274,275 | -77.7% | 200,201 | -60.4% | 0.09% | -76.1% |
NBSE | Exit | NeuBase Therapeutics, Inc. | $0 | – | -50,000 | – | -0.03% | – |
Exit | GeneDx Holdings Corp. | $0 | – | -103,604 | – | -0.19% | – | |
Exit | Apexigen, Inc. | $0 | – | -1,894,551 | – | -0.26% | – | |
Exit | AtriCure Inc. | $0 | – | -46,259 | – | -0.72% | – | |
SGEN | Exit | Seagen Inc. | $0 | – | -23,014 | – | -1.39% | – |
Exit | BeyondSpring Inc. | $0 | – | -4,958,143 | – | -1.84% | – | |
Exit | ROIVANT SCIENCES LTD | $0 | – | -1,459,700 | – | -4.62% | – | |
ALPPRNCL | Exit | Alpine Immune Sciences, Inc. | $0 | – | -6,708,288 | – | -21.63% | – |
Q2 2023
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
ALPPRNCL | New | Alpine Immune Sciences, Inc. | $68,961,201 | – | 6,708,288 | – | 21.63% | – |
ZNTL | New | Zentalis Pharmaceuticals Inc. | $59,229,236 | – | 2,099,583 | – | 18.58% | – |
New | ACELYRIN INC(NSM) | $32,487,315 | – | 1,554,417 | – | 10.19% | – | |
TXG | New | 10x Genomics, Inc. | $20,077,495 | – | 359,554 | – | 6.30% | – |
PACB | New | Pacific Biosciences of California, Inc. | $19,469,498 | – | 1,463,872 | – | 6.11% | – |
RCUS | New | Arcus BioSciences, Inc. | $17,665,435 | – | 869,790 | – | 5.54% | – |
ILMN | New | Illumnia, Inc. | $15,160,254 | – | 80,859 | – | 4.76% | – |
New | ROIVANT SCIENCES LTD | $14,713,776 | – | 1,459,700 | – | 4.62% | – | |
PHAT | New | PHATHOM PHARMACEUTICALS INC | $12,172,000 | – | 850,000 | – | 3.82% | – |
ARGX | New | Argenx SE | $10,689,904 | – | 27,429 | – | 3.35% | – |
HZNP | New | Horizon Therapeutics PLC | $8,114,865 | – | 78,900 | – | 2.54% | – |
TERN | New | Terns Pharmaceuticals, Inc. | $6,249,994 | – | 714,285 | – | 1.96% | – |
New | BeyondSpring Inc. | $5,850,609 | – | 4,958,143 | – | 1.84% | – | |
SGEN | New | Seagen Inc. | $4,429,274 | – | 23,014 | – | 1.39% | – |
New | Aura Biosciences, Inc. | $3,622,663 | – | 293,333 | – | 1.14% | – | |
New | Aadi Bioscience, Inc. | $3,600,090 | – | 526,329 | – | 1.13% | – | |
EQ | New | Equillium Inc. | $3,335,481 | – | 4,447,308 | – | 1.05% | – |
New | Cue Health Inc. | $3,322,936 | – | 8,980,909 | – | 1.04% | – | |
MRSN | New | Mersana Therapeutics, Inc. | $2,975,042 | – | 904,268 | – | 0.93% | – |
New | AtriCure Inc. | $2,283,344 | – | 46,259 | – | 0.72% | – | |
SCYX | New | Scynexis Inc. | $1,638,887 | – | 555,555 | – | 0.51% | – |
ACET | New | Adicet Bio, Inc. | $1,228,773 | – | 505,668 | – | 0.38% | – |
New | Apexigen, Inc. | $814,278 | – | 1,894,551 | – | 0.26% | – | |
New | GeneDx Holdings Corp. | $617,479 | – | 103,604 | – | 0.19% | – | |
NBSE | New | NeuBase Therapeutics, Inc. | $92,500 | – | 50,000 | – | 0.03% | – |
Q4 2022
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
NBSE | Exit | NeuBase Therapeutics, Inc. | $0 | – | -1,000,000 | – | -0.14% | – |
NAUT | Exit | Nautilus Biotechnology, Inc. | $0 | – | -300,000 | – | -0.23% | – |
Exit | Owlet, Inc. | $0 | – | -898,400 | – | -0.35% | – | |
SCYX | Exit | Scynexis Inc. | $0 | – | -555,555 | – | -0.48% | – |
Exit | AtriCure Inc. | $0 | – | -46,259 | – | -0.66% | – | |
ARGX | Exit | Argenx SE | $0 | – | -5,529 | – | -0.71% | – |
Exit | Sema4 Holings Corp. | $0 | – | -3,418,929 | – | -1.09% | – | |
SGEN | Exit | Seagen Inc. | $0 | – | -23,014 | – | -1.14% | – |
Exit | Aura Biosciences, Inc. | $0 | – | -210,000 | – | -1.38% | – | |
TERN | Exit | Terns Pharmaceuticals, Inc. | $0 | – | -714,285 | – | -1.52% | – |
HZNP | Exit | Horizon Therapeutics PLC | $0 | – | -78,900 | – | -1.77% | – |
BYSI | Exit | BeyondSpring Inc. | $0 | – | -4,958,143 | – | -1.78% | – |
Exit | Apexigen, Inc. | $0 | – | -1,894,551 | – | -1.85% | – | |
MRSN | Exit | Mersana Therapeutics, Inc. | $0 | – | -904,268 | – | -2.22% | – |
Exit | Aadi Bioscience, Inc. | $0 | – | -526,329 | – | -2.70% | – | |
ACET | Exit | Adicet Bio, Inc. | $0 | – | -580,000 | – | -2.99% | – |
PACB | Exit | Pacific Biosciences of California, Inc. | $0 | – | -1,463,872 | – | -3.08% | – |
EQ | Exit | Equillium Inc. | $0 | – | -4,447,308 | – | -3.58% | – |
TXG | Exit | 10x Genomics, Inc. | $0 | – | -359,554 | – | -3.71% | – |
ALBO | Exit | Albireo Pharma, Inc. | $0 | – | -623,342 | – | -4.38% | – |
RXDX | Exit | Prometheus Biosciences, Inc. | $0 | – | -250,000 | – | -5.35% | – |
RCUS | Exit | Arcus BioSciences, Inc. | $0 | – | -869,790 | – | -8.25% | – |
ILMN | Exit | Illumnia, Inc. | $0 | – | -130,138 | – | -9.00% | – |
Exit | Cue Health Inc. | $0 | – | -8,980,909 | – | -9.80% | – | |
ZNTL | Exit | Zentalis Pharmaceuticals Inc. | $0 | – | -1,824,583 | – | -14.33% | – |
ALPN | Exit | Alpine Immune Sciences, Inc. | $0 | – | -6,708,288 | – | -17.51% | – |
Q3 2022
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
ALPN | Buy | Alpine Immune Sciences, Inc. | $48,300,000 | +20.5% | 6,708,288 | +42.5% | 17.51% | +15.3% |
ILMN | Sell | Illumnia, Inc. | $24,829,000 | -12.7% | 130,138 | -15.6% | 9.00% | -16.5% |
ALBO | Buy | Albireo Pharma, Inc. | $12,068,000 | +17.2% | 623,342 | +20.3% | 4.38% | +12.1% |
TXG | Buy | 10x Genomics, Inc. | $10,240,000 | -25.6% | 359,554 | +18.3% | 3.71% | -28.8% |
New | Apexigen, Inc. | $5,115,000 | – | 1,894,551 | – | 1.85% | – | |
BYSI | Buy | BeyondSpring Inc. | $4,909,000 | -31.2% | 4,958,143 | +0.0% | 1.78% | -34.2% |
HZNP | Buy | Horizon Therapeutics PLC | $4,883,000 | +10.5% | 78,900 | +42.4% | 1.77% | +5.6% |
SGEN | New | Seagen Inc. | $3,149,000 | – | 23,014 | – | 1.14% | – |
ARGX | New | Argenx SE | $1,952,000 | – | 5,529 | – | 0.71% | – |
OMIC | Exit | Singular Genomics Systems, Inc. | $0 | – | -20,000 | – | -0.03% | – |
MASS | Exit | 908 Devices Inc. | $0 | – | -20,000 | – | -0.16% | – |
Q2 2022
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
ZNTL | New | Zentalis Pharmaceuticals Inc. | $51,271,000 | – | 1,824,583 | – | 19.44% | – |
ALPN | New | Alpine Immune Sciences, Inc. | $40,068,000 | – | 4,708,288 | – | 15.19% | – |
New | Cue Health Inc. | $28,739,000 | – | 8,980,909 | – | 10.90% | – | |
ILMN | New | Illumnia, Inc. | $28,435,000 | – | 154,238 | – | 10.78% | – |
RCUS | New | Arcus BioSciences, Inc. | $22,040,000 | – | 869,790 | – | 8.36% | – |
TXG | New | 10x Genomics, Inc. | $13,755,000 | – | 303,984 | – | 5.22% | – |
ALBO | New | Albireo Pharma, Inc. | $10,294,000 | – | 518,342 | – | 3.90% | – |
EQ | New | Equillium Inc. | $9,073,000 | – | 4,447,308 | – | 3.44% | – |
ACET | New | Adicet Bio, Inc. | $8,468,000 | – | 580,000 | – | 3.21% | – |
BYSI | New | BeyondSpring Inc. | $7,140,000 | – | 4,958,142 | – | 2.71% | – |
RXDX | New | Prometheus Biosciences, Inc. | $7,058,000 | – | 250,000 | – | 2.68% | – |
New | Aadi Bioscience, Inc. | $6,484,000 | – | 526,329 | – | 2.46% | – | |
PACB | New | Pacific Biosciences of California, Inc. | $6,470,000 | – | 1,463,872 | – | 2.45% | – |
HZNP | New | Horizon Therapeutics PLC | $4,419,000 | – | 55,400 | – | 1.68% | – |
New | Sema4 Holings Corp. | $4,308,000 | – | 3,418,929 | – | 1.63% | – | |
MRSN | New | Mersana Therapeutics, Inc. | $4,178,000 | – | 904,268 | – | 1.58% | – |
New | Aura Biosciences, Inc. | $2,976,000 | – | 210,000 | – | 1.13% | – | |
New | AtriCure Inc. | $1,890,000 | – | 46,259 | – | 0.72% | – | |
TERN | New | Terns Pharmaceuticals, Inc. | $1,771,000 | – | 714,285 | – | 0.67% | – |
New | Owlet, Inc. | $1,527,000 | – | 898,400 | – | 0.58% | – | |
NBSE | New | NeuBase Therapeutics, Inc. | $1,050,000 | – | 1,000,000 | – | 0.40% | – |
SCYX | New | Scynexis Inc. | $1,033,000 | – | 555,555 | – | 0.39% | – |
NAUT | New | Nautilus Biotechnology, Inc. | $807,000 | – | 300,000 | – | 0.31% | – |
MASS | New | 908 Devices Inc. | $412,000 | – | 20,000 | – | 0.16% | – |
OMIC | New | Singular Genomics Systems, Inc. | $76,000 | – | 20,000 | – | 0.03% | – |